Dr. Charles Parker has researched the new ADHD medication Intuniv, and reported his finding in a Nov. 28 post on CorePsych Blog. Intuniv (generic name: guanfacine) is a pill that, in case studies, has remained effective for as long as 24 hours.

"There will be few problems with dosing as Intuniv comes closer to absolute simplicity than many of the other ADHD meds," Dr. Parker wrote. "Most [people] did well at 3mg. The dosage is often weight related, but not always& It has an excellent effect on simple inattentive ADD, just for attention, and is approved by the FDA for ADHD."

Dr. Parker reported that first line indications for Intuniv may include Oppositional Defiant Disorder, anger, frustration, and irritation, in spite of doing well on other ADHD meds.

Intuniv is different than most ADHD medications in that it is not a stimulant. According to a Sep. 6 Medical News Today article, Intuniv is "the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD."

Labels: medications, intuniv

Posted By: Aspen/CRC